Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs

Neglected diseases caused by arenaviruses such as Lassa virus (LASV) and filoviruses like Ebola virus (EBOV) primarily afflict resource-limited countries, where antiviral drug development is often minimal. Previous studies have shown that many approved drugs developed for other clinical indications...

Descripción completa

Detalles Bibliográficos
Autores principales: Herring, Shawn, Oda, Jessica M., Wagoner, Jessica, Kirchmeier, Delaney, O’Connor, Aidan, Nelson, Elizabeth A., Huang, Qinfeng, Liang, Yuying, DeWald, Lisa Evans, Johansen, Lisa M., Glass, Pamela J., Olinger, Gene G., Ianevski, Aleksandr, Aittokallio, Tero, Paine, Mary F., Fink, Susan L., White, Judith M., Polyak, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097473/
https://www.ncbi.nlm.nih.gov/pubmed/33468464
http://dx.doi.org/10.1128/AAC.01146-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097473/
https://www.ncbi.nlm.nih.gov/pubmed/33468464
http://dx.doi.org/10.1128/AAC.01146-20

Ejemplares similares